成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 51677-09-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 51677-09-9
Chemical Structure| 51677-09-9
Structure of 51677-09-9 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 51677-09-9 ]

Related Doc. of [ 51677-09-9 ]

Alternatived Products of [ 51677-09-9 ]
Product Citations

Product Details of [ 51677-09-9 ]

CAS No. :51677-09-9 MDL No. :MFCD02159553
Formula : C11H9NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :XMPLCJOQBDGMKT-UHFFFAOYSA-N
M.W : 203.19 Pubchem ID :905953
Synonyms :

Calculated chemistry of [ 51677-09-9 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.09
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 53.22
TPSA : 52.33 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.58 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.29
Log Po/w (XLOGP3) : 2.76
Log Po/w (WLOGP) : 2.13
Log Po/w (MLOGP) : 1.33
Log Po/w (SILICOS-IT) : 2.27
Consensus Log Po/w : 2.15

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.18
Solubility : 0.133 mg/ml ; 0.000656 mol/l
Class : Soluble
Log S (Ali) : -3.51
Solubility : 0.0622 mg/ml ; 0.000306 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.84
Solubility : 0.0295 mg/ml ; 0.000145 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.76

Safety of [ 51677-09-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 51677-09-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 51677-09-9 ]

[ 51677-09-9 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 20577-73-5 ]
  • [ 51677-09-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1998, vol. 41, # 13, p. 2390 - 2410
[2] Journal of Medicinal Chemistry, 2018, vol. 61, # 18, p. 8337 - 8352
[3] Journal of Molecular Structure, 2009, vol. 919, # 1-3, p. 47 - 53
[4] Indian Journal of Heterocyclic Chemistry, 2011, vol. 20, # 3, p. 279 - 280
[5] Journal of Heterocyclic Chemistry, 2003, vol. 40, # 6, p. 1097 - 1102
[6] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2012, vol. 51, # 9, p. 1369 - 1375
[7] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 1, p. 273 - 280
[8] Indian Journal of Heterocyclic Chemistry, 2012, vol. 22, # 1, p. 27 - 30
  • 2
  • [ 1313396-20-1 ]
  • [ 51677-09-9 ]
YieldReaction ConditionsOperation in experiment
81% With silver tetrafluoroborate; phenol In tetrahydrofuran for 12 h; Reflux General procedure: To a solution of alkynyl oxime ether 1 (0.15 mmol) in THF (5 mL) were added phenol (28 mg, 0.3 mmol) and AgBF4 (5.8 mg, 0.03 mmol), with a drying tube filled with silica gel at room temperature. After being stirred at reflux for 1-12 h (TLC monitoring), the reaction mixture was concentrated under reduced pressure. The residue was purified by preparative TLC (hexane/AcOEt=3-10:1) to afford isoxazole 3. The physical and spectroscopic data of 3a5 and 3j12h were in accord with those reported in the literature.
Reference: [1] Tetrahedron, 2011, vol. 67, # 25, p. 4612 - 4615
  • 3
  • [ 30673-27-9 ]
  • [ 536-74-3 ]
  • [ 51677-09-9 ]
YieldReaction ConditionsOperation in experiment
31% With triethylamine In diethyl ether at 20℃; for 9.5 h; Inert atmosphere To a stirred solution of methyl chlorooximidoacetate (235 mg, 1.71 mmol) and phenylacetylene (0.38 mL, 3.42 mmol) in Et2O (8.55 mL) was added Et3N (0.47 mL, 3.42 mmol) at rt under N2 and the resultingsolution was stirred for 9.5 h. Sat. NH4Cl aq. was added to the reaction mixture and the resultingsolution was extracted with AcOEt. The combined organic layer was dried over Na2SO4 andconcentrated in vacuo. The crude product was purified by flash column chromatography on silica gel(hexane/AcOEt = 5/1). The product was obtained as pale yellow oil (108 mg, 31percent);
Reference: [1] Tetrahedron Letters, 2012, vol. 53, # 29, p. 3746 - 3749
  • 4
  • [ 14441-90-8 ]
  • [ 18107-18-1 ]
  • [ 51677-09-9 ]
Reference: [1] Patent: WO2010/85581, 2010, A1, . Location in patent: Page/Page column 82
[2] Journal of Medicinal Chemistry, 2016, vol. 59, # 6, p. 2820 - 2840
  • 5
  • [ 5437-67-2 ]
  • [ 536-74-3 ]
  • [ 51677-09-9 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1985, vol. 58, # 9, p. 2519 - 2522
  • 6
  • [ 2483-57-0 ]
  • [ 536-74-3 ]
  • [ 51677-09-9 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1986, vol. 59, # 9, p. 2827 - 2832
  • 7
  • [ 98-86-2 ]
  • [ 51677-09-9 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2012, vol. 51, # 9, p. 1369 - 1375
[2] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 1, p. 273 - 280
[3] Indian Journal of Heterocyclic Chemistry, 2012, vol. 22, # 1, p. 27 - 30
[4] Journal of Medicinal Chemistry, 2018, vol. 61, # 18, p. 8337 - 8352
  • 8
  • [ 67-56-1 ]
  • [ 14441-90-8 ]
  • [ 51677-09-9 ]
Reference: [1] Synthesis (Germany), 2013, vol. 45, # 2, p. 260 - 264
  • 9
  • [ 2687-43-6 ]
  • [ 51677-09-9 ]
Reference: [1] Tetrahedron, 2011, vol. 67, # 25, p. 4612 - 4615
  • 10
  • [ 20577-73-5 ]
  • [ 51677-09-9 ]
Reference: [1] Archiv der Pharmazie, 1995, vol. 328, # 5, p. 437 - 443
  • 11
  • [ 41158-32-1 ]
  • [ 51677-09-9 ]
Reference: [1] Journal of the Chemical Society, 1950, p. 236,240
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 51677-09-9 ]

Aryls

Chemical Structure| 14441-90-8

[ 14441-90-8 ]

5-Phenylisoxazole-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 925006-96-8

[ 925006-96-8 ]

Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate

Similarity: 0.92

Chemical Structure| 517870-15-4

[ 517870-15-4 ]

Methyl 5-(4-bromophenyl)isoxazole-3-carboxylate

Similarity: 0.91

Chemical Structure| 745078-74-4

[ 745078-74-4 ]

Methyl 5-(3-bromophenyl)isoxazole-3-carboxylate

Similarity: 0.90

Chemical Structure| 33282-16-5

[ 33282-16-5 ]

5-(4-Methoxyphenyl)isoxazole-3-carboxylic acid

Similarity: 0.89

Esters

Chemical Structure| 925006-96-8

[ 925006-96-8 ]

Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate

Similarity: 0.92

Chemical Structure| 517870-15-4

[ 517870-15-4 ]

Methyl 5-(4-bromophenyl)isoxazole-3-carboxylate

Similarity: 0.91

Chemical Structure| 745078-74-4

[ 745078-74-4 ]

Methyl 5-(3-bromophenyl)isoxazole-3-carboxylate

Similarity: 0.90

Chemical Structure| 517870-22-3

[ 517870-22-3 ]

Methyl 5-(tert-butyl)isoxazole-3-carboxylate

Similarity: 0.85

Chemical Structure| 91252-54-9

[ 91252-54-9 ]

Ethyl 5-(tert-butyl)isoxazole-3-carboxylate

Similarity: 0.82

Related Parent Nucleus of
[ 51677-09-9 ]

Isoxazoles

Chemical Structure| 14441-90-8

[ 14441-90-8 ]

5-Phenylisoxazole-3-carboxylic acid

Similarity: 0.93

Chemical Structure| 925006-96-8

[ 925006-96-8 ]

Ethyl 5-(4-methoxyphenyl)isoxazole-3-carboxylate

Similarity: 0.92

Chemical Structure| 517870-15-4

[ 517870-15-4 ]

Methyl 5-(4-bromophenyl)isoxazole-3-carboxylate

Similarity: 0.91

Chemical Structure| 745078-74-4

[ 745078-74-4 ]

Methyl 5-(3-bromophenyl)isoxazole-3-carboxylate

Similarity: 0.90

Chemical Structure| 33282-16-5

[ 33282-16-5 ]

5-(4-Methoxyphenyl)isoxazole-3-carboxylic acid

Similarity: 0.89

; ;